BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28562110)

  • 1. Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis.
    Danielsson Borssén Å; Marschall HU; Bergquist A; Rorsman F; Weiland O; Kechagias S; Nyhlin N; Verbaan H; Nilsson E; Werner M
    Scand J Gastroenterol; 2017 Sep; 52(9):1022-1028. PubMed ID: 28562110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study.
    Grønbæk L; Vilstrup H; Jepsen P
    J Hepatol; 2014 Mar; 60(3):612-7. PubMed ID: 24326217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.
    van den Brand FF; van der Veen KS; de Boer YS; van Gerven NM; Lissenberg-Witte BI; Beuers U; van Erpecum KJ; van Buuren HR; den Ouden JW; Brouwer JT; Vrolijk JM; Verdonk RC; van Hoek B; Koek GH; Drenth JPH; Guichelaar MMJ; Mulder CJJ; Bloemena E; van Nieuwkerk CMJ; Bouma G;
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):940-947.e2. PubMed ID: 30291909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: A nationwide register-based cohort study in Finland.
    Puustinen L; Barner-Rasmussen N; Pukkala E; Färkkilä M
    Dig Liver Dis; 2019 Sep; 51(9):1294-1299. PubMed ID: 30850346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.
    Ngu JH; Gearry RB; Frampton CM; Stedman CA
    Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1.
    Biewenga M; Verhelst XPDMJ; Baven-Pronk MAMC; Putter H; van den Berg AP; van Nieuwkerk KCMJ; van Buuren HR; Bouma G; de Boer YS; Simoen C; Colle I; Schouten J; Sermon F; van Steenkiste C; van Vlierberghe H; van der Meer AJ; Nevens F; van Hoek B;
    United European Gastroenterol J; 2021 Jul; 9(6):662-671. PubMed ID: 34165262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study.
    Werner M; Prytz H; Ohlsson B; Almer S; Björnsson E; Bergquist A; Wallerstedt S; Sandberg-Gertzén H; Hultcrantz R; Sangfelt P; Weiland O; Danielsson A
    Scand J Gastroenterol; 2008; 43(10):1232-40. PubMed ID: 18609163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response.
    Werner M; Wallerstedt S; Lindgren S; Almer S; Björnsson E; Bergquist A; Prytz H; Sandberg-Gertzén H; Hultcrantz R; Sangfelt P; Weiland O; Ohlsson B; Danielsson A
    Scand J Gastroenterol; 2010 Apr; 45(4):457-67. PubMed ID: 20082594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
    De Luca-Johnson J; Wangensteen KJ; Hanson J; Krawitt E; Wilcox R
    Dig Dis Sci; 2016 Sep; 61(9):2710-20. PubMed ID: 27262844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of autoimmune hepatitis presenting with jaundice.
    Panayi V; Froud OJ; Vine L; Laurent P; Woolson KL; Hunter JG; Madden RG; Miller C; Palmer J; Harris N; Mathew J; Stableforth B; Murray IA; Dalton HR
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):640-5. PubMed ID: 24694760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.
    Baven-Pronk MAMC; Biewenga M; van Silfhout JJ; van den Berg AP; van Buuren HR; Verwer BJ; van Nieuwkerk CMJ; Bouma G; van Hoek B
    Clin Transl Gastroenterol; 2018 Jul; 9(6):165. PubMed ID: 29961755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis--a long-term follow-up study in 634 Swedish patients.
    Danielsson Borssén Å; Almer S; Prytz H; Wallerstedt S; Friis-Liby IL; Bergquist A; Nyhlin N; Hultcrantz R; Sangfelt P; Weiland O; Lindgren S; Verbaan H; Werner M
    Scand J Gastroenterol; 2015 Feb; 50(2):217-23. PubMed ID: 25483724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.
    van Gerven NM; Verwer BJ; Witte BI; van Erpecum KJ; van Buuren HR; Maijers I; Visscher AP; Verschuren EC; van Hoek B; Coenraad MJ; Beuers UH; de Man RA; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Mulder CJ; van Nieuwkerk CM; Bouma G;
    Scand J Gastroenterol; 2014 Oct; 49(10):1245-54. PubMed ID: 25123213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.
    Montano-Loza AJ; Vargas-Vorackova F; Ma M; Bain VG; Burak K; Kumar T; Mason AL
    Liver Int; 2012 Oct; 32(9):1426-33. PubMed ID: 22712495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.
    Sharma R; Verna EC; Simon TG; Söderling J; Hagström H; Green PHR; Ludvigsson JF
    Am J Epidemiol; 2022 Jan; 191(2):298-319. PubMed ID: 33913487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study.
    Vaz J; Eriksson B; Strömberg U; Buchebner D; Midlöv P
    BMC Gastroenterol; 2020 Apr; 20(1):84. PubMed ID: 32245414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry.
    Schramm C; Bubenheim M; Adam R; Karam V; Buckels J; O'Grady JG; Jamieson N; Pollard S; Neuhaus P; Manns MM; Porte R; Castaing D; Paul A; Traynor O; Garden J; Friman S; Ericzon BG; Fischer L; Vitko S; Krawczyk M; Metselaar HJ; Foss A; Kilic M; Rolles K; Burra P; Rogiers X; Lohse AW;
    Liver Transpl; 2010 Apr; 16(4):461-9. PubMed ID: 20373456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.